The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy analyses of central laboratory pCR results from the LILAC study comparing the biosimilar ABP 980 and trastuzumab.
 
Hans-Christian Kolberg
Stock and Other Ownership Interests - Theraclion
Honoraria - Amgen; AstraZeneca; Genomic Health; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen; Carl Zeiss Meditec; Genomic Health; Novartis; Pfizer
Research Funding - Amgen (Inst); Novartis (Inst); Pfizer (Inst)
 
Zorica Tomasevic
Travel, Accommodations, Expenses - Roche
 
Georgia Demetriou
Consulting or Advisory Role - AstraZeneca; Celgene
Speakers' Bureau - Merck Serono
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Yasuhiro Fujiwara
Honoraria - AstraZeneca Japan; Chugai Pharma; Daiichi Sankyo; Novartis; Taiho Pharmaceutical
 
Marco Colleoni
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Celldex; OBI Pharma; Pfizer; Pierre Fabre; Puma Biotechnology
 
Hans Tesch
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Patricia Xavier Santi
Consulting or Advisory Role - Janssen
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Medivation (Inst)
Travel, Accommodations, Expenses - Aché; AstraZeneca; Roche
 
Vladimir Hanes
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Nan Zhang
Employment - Amgen
Stock and Other Ownership Interests - Amgen